Office of Biotechnology Activities, Office of Science Policy, Office of the Director, Notice of Meeting, 32992 [06-5150]
Download as PDF
32992
Federal Register / Vol. 71, No. 109 / Wednesday, June 7, 2006 / Notices
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, Loan Repayment Program.
Date: June 6, 2006.
Time: 1 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health, 5635
Fishers Lane, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Katrina L. Foster, Ph.D.,
Scientific Review Administrator, National
Institute on Alcohol Abuse and Alcoholism,
National Institutes of Health, 5636 Fishers
Lane, Rm. 3042, Rockville, MD 20852. 301
443—4032. katrina@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: May 31, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5157 Filed 6–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
rwilkins on PROD1PC63 with NOTICES
Office of Biotechnology Activities,
Office of Science Policy, Office of the
Director, Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
National Science Advisory Board for
Biosecurity (NSABB).
Under authority 42 U.S.C. 217a,
section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
NSABB to provide advice, guidance and
leadership regarding federal oversight of
dual use research, defined as biological
research with legitimate scientific
purpose that could be misused to pose
a biological threat to public health and/
or national security.
The meeting will be open the public,
however pre-registration is strongly
recommended due to space limitations.
VerDate Aug<31>2005
17:54 Jun 06, 2006
Jkt 208001
Persons planning to attend should
register online at https://
www.biosecurityboard.gov/meetings.asp
or by calling Capitol Consulting
Corporation (Contact: Saundra M.
Bromberg), at 301–468–6004, ext. 406.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
indicate these requirements upon
registration.
Name of Committee: National Advisory
Board for Biosecurity.
Date: July 13, 2006.
Open: 8 a.m. to 6 p.m.
Agenda: Presentations and discussions
regarding: (1) Criteria for defining dual use
research in the life sciences; (2) the role of
a code of conduct for the life sciences; (3)
communications of dual use research; (4)
international perspectives on dual use
research; (5) public comments; and (6) and
other business of the Board.
Place: The National Institutes of Health, 31
Center Drive, Building 31, 6C—Room 10,
Bethesda, Maryland 20892.
Contact Person: Laurie Lelwallen, NSABB
Program Assistant, 6705 Rockledge Drive,
Bethesda, Maryland 20892, (301) 496–9838.
This meeting will also be Webcast. The
draft meeting agenda and other information
about NSABB, including information about
access to the Webcast and pre-registration,
will be available at https://
www.biosecurityboard.gov/meetings.asp.
Any member of the public interested in
presenting oral comments at the meeting may
notify the Contact Person listed on this notice
at least 10 days in advance of the meeting.
Interested individuals and representatives of
an organization may submit a letter of intent,
a brief description of the organization
represented and a short description of the
oral presentation. Only one representative of
an organization may be allowed to present
oral comments. Both printed and electronic
copies are requested for the record. In
addition, any interested person may file
written comments with the committee. All
written comments must be received by June
30, 2006 and should be sent via e-mail to
nsabb@od.nih.gov with ‘‘NSABB Public
Comment’’ as the subject line or by regular
mail to 6705 Rockledge Drive, Suite 750,
Bethesda, MD 20892, Attention Laurie
Lewallen. The statement should include the
name, address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example,
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Dated: May 21, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5150 Filed 6–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; B&T Cell
Development and Evolution.
Date: June 15, 2006.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Betty Hayden, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892. 301–435–
1223. haydenb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; HAI
Overflow Special Emphasis Panel Review.
Date: June 22, 2006.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Jin Huang, PhD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4095G, MSC 7812,
Bethesda, MD 20892. 301–435–1187.
jh377p@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Risk and
Substance Abuse.
Date: June 22, 2006.
Time: 9 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\07JNN1.SGM
07JNN1
Agencies
[Federal Register Volume 71, Number 109 (Wednesday, June 7, 2006)]
[Notices]
[Page 32992]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5150]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of Biotechnology Activities, Office of Science Policy,
Office of the Director, Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the National Science Advisory Board for Biosecurity (NSABB).
Under authority 42 U.S.C. 217a, section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established NSABB to provide advice, guidance and leadership regarding
federal oversight of dual use research, defined as biological research
with legitimate scientific purpose that could be misused to pose a
biological threat to public health and/or national security.
The meeting will be open the public, however pre-registration is
strongly recommended due to space limitations. Persons planning to
attend should register online at https://www.biosecurityboard.gov/
meetings.asp or by calling Capitol Consulting Corporation (Contact:
Saundra M. Bromberg), at 301-468-6004, ext. 406. Individuals who plan
to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should indicate
these requirements upon registration.
Name of Committee: National Advisory Board for Biosecurity.
Date: July 13, 2006.
Open: 8 a.m. to 6 p.m.
Agenda: Presentations and discussions regarding: (1) Criteria
for defining dual use research in the life sciences; (2) the role of
a code of conduct for the life sciences; (3) communications of dual
use research; (4) international perspectives on dual use research;
(5) public comments; and (6) and other business of the Board.
Place: The National Institutes of Health, 31 Center Drive,
Building 31, 6C--Room 10, Bethesda, Maryland 20892.
Contact Person: Laurie Lelwallen, NSABB Program Assistant, 6705
Rockledge Drive, Bethesda, Maryland 20892, (301) 496-9838.
This meeting will also be Webcast. The draft meeting agenda and
other information about NSABB, including information about access to
the Webcast and pre-registration, will be available at https://
www.biosecurityboard.gov/meetings.asp.
Any member of the public interested in presenting oral comments
at the meeting may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of an organization may submit a letter of
intent, a brief description of the organization represented and a
short description of the oral presentation. Only one representative
of an organization may be allowed to present oral comments. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee. All written comments must be received by June 30, 2006
and should be sent via e-mail to nsabb@od.nih.gov with ``NSABB
Public Comment'' as the subject line or by regular mail to 6705
Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Laurie
Lewallen. The statement should include the name, address, telephone
number and, when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Dated: May 21, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5150 Filed 6-6-06; 8:45 am]
BILLING CODE 4140-01-M